Skip to content

Advertisement

  • Correction
  • Open Access

Correction to: The role of fibrinolysis inhibition in engineered vascular networks derived from endothelial cells and adipose-derived stem cells

  • 1, 2,
  • 1, 2,
  • 1, 2, 6,
  • 1, 2,
  • 1, 2,
  • 3,
  • 4,
  • 5,
  • 1, 2 and
  • 1, 2Email author
Contributed equally
Stem Cell Research & Therapy20189:261

https://doi.org/10.1186/s13287-018-1001-3

  • Received: 27 June 2018
  • Accepted: 29 August 2018
  • Published:

The original article was published in Stem Cell Research & Therapy 2018 9:35

Correction

The original article [1] contains numerous value errors in the graphs in Fig. 2b regarding the markers describing the values for total tubule length and mean tubule length without aprotinin at 2.5 mg/ml concentration of fibrinogen. The corrected version of this figure can be viewed ahead.

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, AUVA Research Centre, Donaueschingenstrasse 13, A-1200 Vienna, Austria
(2)
Austrian Cluster for Tissue Regeneration, Vienna, Austria
(3)
Institute of Molecular Biotechnology of the Austrian Academy of Science (IMBA), Vienna Biocenter (VBC), Vienna, Austria
(4)
Department of Biotechnology, University of Natural Resources and Life Sciences (BOKU), Vienna, Austria
(5)
TissUse GmbH, Berlin, Germany
(6)
Present address: Division of Plastic and Reconstructive Surgery, Department of Surgery, Medical University of Vienna, Vienna, Austria

Reference

  1. Mühleder S, et al. The role of fibrinolysis inhibition in engineered vascular networks derived from endothelial cells and adipose-derived stem cells. Stem Cell Res Ther. 2018;9:35. https://doi.org/10.1186/s13287-017-0764-2 View ArticleGoogle Scholar

Copyright

© The Author(s). 2018

Advertisement